Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,420
Closed -$592K 202
2025
Q2
$592K Buy
15,420
+507
+3% +$19.4K 0.36% 89
2025
Q1
$578K Buy
14,913
+6,950
+87% +$254K 0.38% 83
2024
Q4
$269K Sell
7,963
-4,531
-36% -$163K 0.19% 148
2024
Q3
$511K Buy
+12,494
New +$511K 0.35% 84

Other funds holding GSK

Everstar Asset Management's GSK Position: Q3 2025 in Review

Everstar Asset Management sold out of GSK (GSK) in Q3 2025, closing a stake of 15,420 shares — an estimated $592K sold.

Everstar Asset Management first reported a position in GSK in Q3 2024 and held it in 4 quarters. The position peaked at $592K in Q2 2025. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Everstar Asset Management reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • Everstar Asset Management sold 15,420 GSK shares in Q3 2025, an estimated $592K.
  • Everstar Asset Management first reported a position in GSK in Q3 2024 and held it in 4 quarters.
  • Everstar Asset Management's GSK position peaked at $592K in Q2 2025.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Everstar Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.